Gonococcal Isolate Surveillance Project
OMB 0920-0307
Robert Kirkcaldy, Project Officer
Attachment 8
Data Dictionary
GISP Data Elements
Demographic/Clinical Data (Form 1 or CDC 73.60A)
Variable Name |
Type/Length |
Description |
Values |
|
CLINIC
YRMO
TOTYRMO
EPFEM
EPMALE
TOTEP
ID
CLINID
SEX
ETHNIC
AMIND
ASIAN
BLACK
NAHAW
WHITE
ORACE
DATEVIS |
[Char, 3]
[Char, 6]
[Char, 6]
[Num, 3]
[Num, 3]
[Num, 3]
[Char, 2]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Date, 10] |
Sentinel site code
Year/Month of patient’s visit
Year/Month of clinic totals for gonorrhea
total monthly female gonorrhea episodes
total monthly male gonorrhea episodes
total monthly gonorrhea episodes
patient or isolate number
clinic identifier number
gender
Hispanic origin
American Indian/ Alaskan Native
Asian
Black
Native Hawaiian/ Pacific Islander
White
Other race
date of clinic visit |
ALB=Albuquerque, ATL=Atlanta, BAL=Baltimore, BHM=Birmingham, CHI=Chicago, CIN=Cincinnati, CLE=Cleveland, DAL=Dallas, DEN=Denver, DTR=Detroit, GRB=Greensboro, HON=Honolulu, KCY=Kansas City, LAX=Los Angeles, LVG=Las Vegas, MIA=Miami, MIN=Minneapolis, NOR=New Orleans, NYC=New York City, OKC=Oklahoma City, ORA=Orange County, PHI=Philadelphia, PHX=Phoenix, POR=Portland, RIC=Richmond, SDG=San Diego, SEA=Seattle, SFO=San Francisco, TRP=Tripler Army Medical Center
YYYYMM
YYYYMM
01, 02, 03, ... 30 or higher
1=male, 2=female, 9=unknown
1=Hispanic, 2=non-Hispanic, 9=Unknown
1= yes, 2= no
1= yes, 2= no
1= yes, 2= no
1= yes, 2= no
1= yes, 2= no
1= yes, 2= no
MM/DD/YYYY |
|
DOB AGE SEXOR
SYMP
REASON
HISTORY
EPSDS
ZIP
HIVSTAT
TRAVEL
SEXWK
ANTIBIOT
IDU
NONIDU
|
[Date, 10] [Num, 2] [Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Num, 2]
[Char, 5]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
[Char, 1]
|
date of birth age in years sexual orientation
symptoms of gonorrhea
reason for clinic visit
previous history of gonorrhea
number of previous episodes within the past 12 months
zip code (residential)
most recent known HIV status at clinic visit for gonorrhea
travel to Hawaii or outside U.S. in the previous 60 days
history of giving or receiving drugs/money for sex in the previous 60 days
any antibiotic use during the previous 60 days
history of injection drug use in previous 60 days
history of noninjection recreational drug use (excluding alcohol) in the previous 60 days
|
MM/DD/YYYY
1= heterosexual, 2= homosexual, 3=bisexual, 9= unknown
1= discharge and/or dysuria, 2= no discharge or dysuria, 9= symptoms unknown
1=volunteer, 2=contact of gonorrhea patient, 3=test of cure, 8=other, 9=unknown
1=yes, 2=no, 9=unknown
0=no documented previous episodes in the past 12 months 99=unknown (patient record not available)
00000=homeless, 99999=unknown
1=positive, 2=negative, 3=indeterminate, 9=unknown
1=yes, 2=no, 9=unknown
1=yes, 2=no, 9=unknown
1=yes, 2=no, 9=unknown
1=yes, 2=no, 9=unknown
1=yes, 2=no, 9=unknown
|
|
TRMT1
OTHTRMT1
TRMT2 |
[Char, 2]
[Char, 15]
[Char, 2] |
primary treatment for gonorrhea
alternative primary therapy for gonorrhea
treatment for presumptive chlamydial coinfection |
00=none, 03=spectinomycin (Trobicin) 2 g, 04=ceftriaxone (Rocephin) 250 mg, 05=ceftriaxone (Rocephin) 125 mg, 06=ciprofloxacin (Cipro) 500 mg, 07=cefoxitin (Mefoxin) 2 g, 12=cefixime (Suprax) 400 mg, 14=cefpodoxime proxetil (Vantin) 200 mg, 15=ofloxacin (Floxin) 400 mg, 17=ceftizoxime (Cefizox) 500 mg, 18=cefotaxime (Claforan) 500 mg, 21=azithromycin (Zithromax) 2 g, 22=levofloxacin (Levaquin) 250 mg, 23=cefpodoxime proxetil (Vantin) 400 mg, 24=ceftibuten (Cedax) 400 mg, 25=cefdinir (Omnicef) 300 mg, 26=cefdinir (Omnicef) 600 mg, 88=other (please indicate in othtrmt1), 99=unknown
If code 88 was entered for Treatment 1, write in the name of the alternative
00=none, 01=ampicillin/amoxicillin, 09=doxycycline (Vibramycin)/tetracycline, 10=erythromycin, 11=azithromycin (Zithromax) 1 gm, 15=ofloxacin (Floxin), 88=other, 99=unknown |
GISP Data Elements
Antimicrobial Susceptibility Testing (Form 2 or CDC 73.60B)
Variable Name |
Type/Length |
Description |
Values |
CLINIC
YRMO
ID
B_LAC
PEN
TETRACY
SPCTINO
CFX
CRO
CIPRO
CPD
AZI
DATETEST
CONTROL |
[Char, 3]
[Char, 6]
[Char, 2]
[Char, 1]
[Num, 6]
[Num, 6]
[Char, 1]
[Num, 6]
[Num, 6]
[Num, 6]
[Num, 6]
[Num, 6]
[Date, 10]
[Char, 1] |
Sentinel site code
Year/ Month of patient's visit
patient or isolate number
beta-lactamase test
penicillin MIC
tetracycline MIC
spectinomycin sensitivity
cefixime MIC
ceftriaxone MIC
ciprofloxacin MIC
cefpodoxime MIC
azithromycin MIC
date isolate tested
Control ID |
ALB=Albuquerque, ATL=Atlanta, BAL=Baltimore, BHM=Birmingham, CHI=Chicago, CIN=Cincinnati, CLE=Cleveland, DAL=Dallas, DEN=Denver, DTR=Detroit, GRB=Greensboro, HON=Honolulu, KCY=Kansas City, LAX=Los Angeles, LVG=Las Vegas, MIA=Miami, MIN=Minneapolis, NOR=New Orleans, NYC=New York City, OKC=Oklahoma City, ORA=Orange County, PHI=Philadelphia, PHX=Phoenix, POR=Portland, RIC=Richmond, SDG=San Diego, SEA=Seattle, SFO=San Francisco, TRP=Tripler Army Medical Center
01, 02, 03, ... 30 or higher
1=positive, 2=negative
0.0008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0
0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0
1=sensitive; 2=resistant
0.002; 0004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0
0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0
0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0
0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0
0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0
MM/DD/YYYY A, B, C, D |
GISP Data Elements
Control Strain Susceptibility Testing (Form 3 or CDC 73.60C)
Variable Name |
Type/Length |
Description |
Values |
LAB
CONTROL
STRAIN
B_LAC
PEN
TETRACY
SPCTINO
CFX
CRO
CIPRO
CPD
AZI
DATETEST |
[Char, 3]
[Char, 1]
[Char, 9]
[Char, 1]
[Num, 6]
[Num, 6]
[Char, 1]
[Num, 6]
[Num, 6]
[Num, 6]
[Num, 6]
[Num, 6]
[Date, 10]
|
Regional laboratory
Control ID
strain number
beta-lactamase test
penicillin MIC
tetracycline MIC
spectinomycin sensitivity
cefixime MIC
ceftriaxone MIC
ciprofloxacin MIC
cefpodoxime MIC
azithromycin MIC
date of isolate testing
|
EMO=Atlanta regional lab UAB=Birmingham regional lab CLV=Cleveland regional lab TEX=Texas regional lab UWA=Seattle regional lab
A, B, C, D
F-18 F-28 SPL-4 P681E CDC 10328 CDC 10329 SPJ-15
1=positive, 2=negative
0.0008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0
0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0; 64.0
1=sensitive; 2=resistant
0.002; 0004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0
0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0
0.001; 0.002; 0.004; 0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0; 32.0
0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0
0.008; 0.015; 0.03; 0.06; 0.125; 0.25; 0.5; 1.0; 2.0; 4.0; 8.0; 16.0
MM/DD/YYYY |
-
File Type | application/msword |
File Title | GISP Data Elements |
Author | Alesia Harvey |
Last Modified By | ixl3 |
File Modified | 2010-06-24 |
File Created | 2010-06-11 |